Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation?

Cellular Immunology

Volumn 262, Issue 2, 2010, Pages 134-140

  Sierra, Beatriz ^a   Perez, Ana B ^a   Vogt, Katrin ^b   Garcia, Gissel ^a   Schmolke, Kathrin ^b   Aguirre, Eglys ^a   Alvarez, Mayling ^a   Kern, Florian ^b   Kourí, Gustavo ^a   Volk, Hans Dieter ^b   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Dengue; Immunopathogenesis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CUBA; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; INFECTION RISK; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEROTYPE;

ADULT; CUBA; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC MEMORY; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

DENGUE VIRUS;

EID: 77950867164     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.02.005     Document Type: Article

References (59)

1. Henchal E.A., Putnak J.R. The dengue viruses. Clin. Microbiol. Rev. 1990, 3:376-396.
2. Hayes E.B., Gubler D.J. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 1992, 11:311-317.
3. Monath T.P. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 1994, 91:2395-2400.
4. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp. Immunol. Microbiol. Infect. Dis. 2007, 30:329-340.
5. Chaturvedi U.C., Agarwal R., Elbishbishi E.A., Mustafa A.S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol. Med. Microbiol. 2000, 28:183-188.
6. Mathew A., Rothman A.L. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 2008, 225:300-313.
7. Suharti C., van Gorp E.C., Setiati T.E., Dolmans W.M., Djokomoeljanto R.J., Hack C.E., Ten C.H., van der Meer J.W. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb. Haemost. 2002, 87:42-46.
8. Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 2003, 60:397-419.
9. Mangada M.M., Rothman A.L. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J. Immunol. 2005, 175:2676-2683.
10. Fink J., Gu F., Vasudevan S.G. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 2006, 16:263-275.
11. Bravo J.R., Guzman M.G., Kouri G.P. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans. R. Soc. Trop. Med. Hyg. 1987, 81:816-820.
12. González D., Castro O.E., Kourí G., Perez J., Martinez E., Vazquez S., Rosario D., Cancio R., Guzman M.G. Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. Int. J. Infect. Dis. 2005, 9:280-285.
13. Vazquez S., Bravo J.R., Perez A.B., Guzman M.G. Inhibition ELISA. Its utility for classifying a case of dengue. Rev. Cubana Med. Trop. 1997, 49:108-112.
14. Alvarez Vera M., Valdes Palacios D., Vazquez Ramudo S., Delgado Hernandez I., Garcia Infante S., Morier Diaz L., Guzman Tirado M.G. The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection. Rev. Cubana Med. Trop. 1998, 50:177-181.
15. Alvarez M., Rodriguez-Roche R., Bernardo L., Morier L., Guzman G. Improved Dengue virus plaque formation on BHK21 and LLCMK2 cells: evaluation of some factors. Dengue Bull. 2005, 29.
16. Morens D.M., Halstead S.B., Repik P.M., Putvatana R., Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 1985, 22:250-254.
17. PAHO, Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control, Scientific Publication No. 548, PAHO, Washington, 1994.
18. Rodriguez-Roche R., Alvarez M., Guzman M.G., Morier L., Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J. Clin. Microbiol. 2000, 38:3508-3510.
19. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 1992, 30:545-551.
20. Vazquez S., Saenz E., Huelva G., Gonzalez A., Kouri G., Guzman M. Deteccion de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro. [Detection of IgM against the dengue++ virus in whole blood absorbed on filter paper]. Rev. Panam. Salud Publica 1998, 3:174-178.
21. Leclerc C., Deriaud E., Megret F., Briand J.P., Van Regenmortel M.H., Deubel V. Identification of helper T cell epitopes of dengue virus E-protein. Mol. Immunol. 1993, 30:613-625.
22. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 1968, 21:77-89.
23. Sierra B., Garcia G., Perez A.B., Morier L., Rodriguez R., Alvarez M., Guzman M.G. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int. J. Infect. Dis. 2002, 6:125-128.
24. Guzman M.G., Garcia G., Kouri G. Dengue and dengue hemorrhagic fever: research priorities. Rev. Panam. Salud Publica 2006, 19:204-215.
25. Guzman M.G. Global voices of science. Deciphering dengue: the Cuban experience. Science 2005, 309:1495-1497.
26. Guzman M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 1990, 42:179-184.
27. Alvarez M., Rodriguez-Roche R., Bernardo L., Vazquez S., Morier L., Gonzalez D., Castro O., Kouri G., Halstead S.B., Guzman M.G. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am. J. Trop. Med. Hyg. 2006, 75:1113-1117.
28. Green S., Rothman A.L. Immunopathological mechanism in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 2006, 19:429-436.
29. Kurane I., Rothman A.L., Livingston P.G., Green S., Gagnon S.J., Janus J., Innis B.L., Nimmannitya S., Nisalak A., Ennis F.A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 1994, 9:59-64.
30. Rothman A.L., Ennis F.A. Immunopathogenesis of Dengue hemorrhagic fever. Virology 1999, 257:1-6.
31. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 2004, 113:946-951.
32. Chakravarti A., Kumaria R. Circulating levels of tumour necrosis factor-alpha & interferon-gamma; in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J. Med. Res. 2006, 123:25-30.
33. Bashyam H.S., Green S., Rothman A.L. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J. Immunol. 2006, 176:2817-2824.
34. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Rothman A.L., Livingston P.G., Janus J., Ennis F.A. Human immune responses to dengue viruses. Southeast Asian J. Trop. Med. Public Health 1990, 21:658-662.
35. Kontny U., Kurane I., Ennis F.A. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J. Virol. 1988, 62:3928-3933.
36. Kurane I., Mady B.J., Ennis F.A. Antibody-dependent enhancement of dengue virus infection. Rev. Med. Virol. 1991, 1:211-221.
37. Cardier J.E., Marino E., Romano E., Taylor P., Liprandi F., Bosch N., Rothman A.L. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 2005, 30:359-365.
38. Guzman G.P.K.M.G., Vazquez S., Rosario D., Bravo J.R., Valdez L. HF Epidemics in Cuba, 1981 and 1997: some interesting observations. Dengue Bull. 1999, WHO 23.
39. Guzman M.G., Kouri G. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:522-523.
40. Rodriguez-Roche R., Alvarez M., Holmes E.C., Bernardo L., Kouri G., Gould E.A., Halstead S., Guzman M.G. Dengue virus type 3, Cuba, 2000-2002. Emerg. Infect. Dis. 2005, 11:773-774.
41. Guzman M.G., Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 2003, 27:1-13.
42. Kouri G., Guzman M.G., Valdes L., Carbonel I., del Rosario D., Vazquez S., Laferte J., Delgado J., Cabrera M.V. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg. Infect. Dis. 1998, 4:89-92.
43. Halstead S. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am. J. Epidemiol. 1981, 114:632-648.
44. Halstead S.B. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 1970, 42:350-362.
45. Halstead S.B., Rojanasuphot S., Sangkawibha N. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 1983, 32:154-156.
46. Halstead S.B. Dengue in the health transition. Gaoxiong Yi Xue Ke Xue Za Zhi 1994, 10(Suppl.):S2-S14.
47. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Meager A., Janus J., Ennis F.A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J. Clin. Invest. 1991, 88:1473-1480.
48. Green S., Pichyangkul S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Nisalak A., Kurane I., Rothman A.L., Ennis F.A. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 1999, 180:1429-1435.
49. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., Ennis F.A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 1999, 179:755-762.
50. Guzman M.G., Kouri G., Valdes L., Bravo J., Vazquez S., Halstead S.B. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev. Panam. Salud Publica 2002, 11:223-227.
51. Guzman M.G., Kouri G., Bravo J., Valdes L., Vazquez S., Halstead S.B. Effect of age on outcome of secondary dengue 2 infections. Int. J. Infect. Dis. 2002, 6:118-124.
52. Halstead S.B. Dengue. Curr. Opin. Infect. Dis. 2002, 15:471-476.
53. Perez A.B., Garcia G., Sierra B., Alvarez M., Vazquez S., Cabrera M.V., Rodriguez R., Rosario D., Martinez E., Denny T., Guzman M.G. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J. Med. Virol. 2004, 73:230-234.
54. Chen R.F., Yang K.D., Wang L., Liu J.W., Chiu C.C., Cheng J.T. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1106-1113.
55. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 2006, 74:142-147.
56. Guzman M.G., Kouri G., Morier L., Soler M., Fernandez A. A study of fatal hemorrhagic dengue cases in Cuba, 1981. Bull. Pan. Am. Health Organ 1984, 18:213-220.
57. Guzman M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., Santos M., Villaescusa R., Basanta P., Indan G., Ballester J.M. Dengue haemorrhagic fever in Cuba. II. Clinical investigations. Trans. R. Soc. Trop. Med. Hyg. 1984, 78:239-241.
58. Kouri G., Guzman M.G., Bravo J. Hemorrhagic dengue in Cuba: history of an epidemic. Bull. Pan. Am. Health Organ 1986, 20:24-30.
59. Luhn K., Simmons C.P., Moran E., Dung N.T., Chau T.N., Quyen N.T., Thao le T.T., Van Ngoc T., Dung N.M., Wills B., Farrar J., McMichael A.J., Dong T., Rowland-Jones S. Increased frequencies of CD4+ CD25 (high) regulatory T cells in acute dengue infection. J. Exp. Med. 2007, 204:979-985.